• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脑叶内出血:接受抗血小板或抗凝治疗患者的系列分析和特征。

Lobar intracerebral haemorrhage: analysis of a series and characteristics of patients receiving antiplatelet or anticoagulation treatment.

机构信息

Sección de Neurología, Hospital do Meixoeiro (CHUVI), Vigo, Pontevedra, Spain.

出版信息

Neurologia. 2012 Sep;27(7):387-93. doi: 10.1016/j.nrl.2011.07.011. Epub 2011 Oct 22.

DOI:10.1016/j.nrl.2011.07.011
PMID:22018825
Abstract

INTRODUCTION

Lobar intracerebral haemorrhage (LIH), is a rare cause of stroke which accounts for about 20% of primary intracerebral haemorrhages. The most common causes are cerebral amyloid angiopathy (CAA), high blood pressure and others, such as using anti-platelet or anticoagulation agents. We analysed a series of patients with LIH and compared it with subgroups of patients with LIH who were previously receiving anti-platelet or anticoagulation agents. We determined the volume of the bleeding and its predictive value for mortality.

PATIENTS AND METHODS

We consecutively and retrospectively included 162 patients diagnosed with LIH and cared for in the Neurology Department of Hospital Meixoeiro in Vigo between 1991 and 2009. We collected demographic characteristics, risk factors, aetiologies and symptoms, and conducted a comparative analysis between the general series and the subgroups of patients receiving anticoagulation and anti-platelet agents.

RESULTS

In the general series, the most common cause was possible or probable CAA followed by hypertension. In the subgroup of patients receiving anti-platelet or anticoagulation agents there were no differences in the variables studied, except for the frequency of heart disease. Nonetheless, there were differences with respect to age, heart disease and bleeding volume between the general series (patients not treated with anti-platelet or anticoagulation agents) when compared with the subgroups of patients receiving anti-platelet and anticoagulation agents.

CONCLUSIONS

We provide new information regarding the clinical behaviour of LIH and its differences in patients receiving anti-platelet or anticoagulation agents. Mortality is higher in cases of LIH on anticoagulants. LIH. Female sex and the volume of bleeding are predictors of mortality.

摘要

简介

脑叶内出血(LIH)是一种罕见的中风病因,占原发性脑内出血的约 20%。最常见的病因是脑淀粉样血管病(CAA)、高血压和其他原因,如使用抗血小板或抗凝药物。我们分析了一系列 LIH 患者,并将其与先前接受抗血小板或抗凝药物治疗的 LIH 患者亚组进行比较。我们确定了出血量及其对死亡率的预测价值。

患者和方法

我们连续回顾性地纳入了 1991 年至 2009 年期间在维哥梅西欧罗医院神经内科就诊的 162 名诊断为 LIH 的患者。我们收集了人口统计学特征、危险因素、病因和症状,并对一般系列和接受抗凝和抗血小板药物治疗的亚组患者进行了比较分析。

结果

在一般系列中,最常见的病因是可能或可能的 CAA,其次是高血压。在接受抗血小板或抗凝药物治疗的亚组患者中,除了心脏病的发生率外,研究变量没有差异。然而,与未接受抗血小板或抗凝药物治疗的一般系列患者(即未接受抗血小板或抗凝药物治疗的患者)相比,年龄、心脏病和出血量在一般系列和接受抗血小板和抗凝药物治疗的亚组患者之间存在差异。

结论

我们提供了关于 LIH 临床行为及其在接受抗血小板或抗凝药物治疗的患者中的差异的新信息。抗凝治疗的 LIH 患者死亡率更高。女性性别和出血量是死亡率的预测因素。

相似文献

1
Lobar intracerebral haemorrhage: analysis of a series and characteristics of patients receiving antiplatelet or anticoagulation treatment.脑叶内出血:接受抗血小板或抗凝治疗患者的系列分析和特征。
Neurologia. 2012 Sep;27(7):387-93. doi: 10.1016/j.nrl.2011.07.011. Epub 2011 Oct 22.
2
[Lobar intracerebral haemorrhage and cerebral amyloid angiopathy: analysis of a series of 106 patients].[脑叶脑出血与脑淀粉样血管病:106例患者系列分析]
Neurologia. 2009 Jul-Aug;24(6):386-90.
3
[Cerebral haemorrhage in patients treated with oral anticoagulation].口服抗凝治疗患者的脑出血
Rev Neurol. 2005;40(1):19-22.
4
Dementia is strongly associated with 90-day mortality in lobar cerebral amyloid angiopathy related intra-cerebral haemorrhage.痴呆与脑叶性脑淀粉样血管病相关脑出血的 90 天死亡率密切相关。
J Neurol Sci. 2012 Nov 15;322(1-2):161-5. doi: 10.1016/j.jns.2012.07.047. Epub 2012 Aug 9.
5
[Platelet antiaggregation and hemorrhagic risk in hemodialysis].[血液透析中的血小板抗聚集与出血风险]
Nefrologia. 2002;22(5):456-62.
6
Subretinal hemorrhages associated with age-related macular degeneration in patients receiving anticoagulation or antiplatelet therapy.接受抗凝或抗血小板治疗的与年龄相关性黄斑变性相关的视网膜下出血。
Am J Ophthalmol. 2010 Feb;149(2):316-321.e1. doi: 10.1016/j.ajo.2009.08.033. Epub 2009 Nov 24.
7
[Is the international normalised ratio a prognostic factor of mortality in intracerebral haemorrhage?].[国际标准化比值是脑出血死亡率的预后因素吗?]
Neurologia. 2011 Nov;26(9):528-32. doi: 10.1016/j.nrl.2010.12.018. Epub 2011 Mar 16.
8
Combination oral antiplatelet therapy may increase the risk of hemorrhagic complications in patients with acute ischemic stroke caused by large artery disease.联合口服抗血小板治疗可能会增加大动脉疾病引起的急性缺血性脑卒中患者出血性并发症的风险。
Thromb Res. 2011 Dec;128(6):541-6. doi: 10.1016/j.thromres.2011.06.009. Epub 2011 Jul 7.
9
Recurrent stroke after lobar and deep intracerebral hemorrhage: a hospital-based cohort study.脑叶和深部脑出血后再发卒中:一项基于医院的队列研究。
Cerebrovasc Dis. 2011;32(3):283-8. doi: 10.1159/000330643. Epub 2011 Aug 31.
10
Effect of anticoagulant and antiplatelet therapy in patients with spontaneous intra-cerebral hemorrhage: Does medication use predict worse outcome?抗凝和抗血小板治疗对自发性脑出血患者的影响:药物使用是否预示更差的预后?
Clin Neurol Neurosurg. 2010 May;112(4):275-81. doi: 10.1016/j.clineuro.2009.12.002. Epub 2009 Dec 29.

引用本文的文献

1
Intracranial haemorrhage and falls: cause or effect?颅内出血与跌倒:原因还是结果?
Ir J Med Sci. 2023 Oct;192(5):2387-2390. doi: 10.1007/s11845-022-03222-4. Epub 2022 Dec 19.
2
Effects of Prior Antiplatelet Therapy on the Prognosis of Primary Intracerebral Hemorrhage: A Meta-analysis.抗血小板治疗对原发性脑出血预后的影响:一项荟萃分析。
Chin Med J (Engl). 2017 Dec 20;130(24):2969-2977. doi: 10.4103/0366-6999.220302.